180 Maiden Ln,Suite 1302
New York , NY, 10038-4925

Rank

Rank Universe

Summary

The fund seeks total return in the long term by investing in mid-and large-size companies outside the United States.

The sub-adviser’s investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.

Next, the research team evaluates a company’s core business, environmental and social fa More

Link

Directors

Oct 16, 2023
  • Amy L. Domini
  • John Shields
  • Gregory Ratliff
  • Caroline Flammer

Chief Compliance Officer

  • Maurizio Tallini

Fund Manager(s)

  • David Elliott
  • Christopher Grohe

Price

  • $ 9.82 ( +0.1 )
    Jul 26, 2024
    Last Close
  • Net Assets
  • $800.5M
    Mar 27, 2024
  • Holding
  • 165
    Sep 30, 2024
    More

  • 52-Week High/Low
  • $10.16 - $7.75
  • Turnover
  • 98%
  • Expense Ratio
  • 1.39%

Company Name

Holding

Novo Nordisk A/S 4.12 %
Novartis AG 4.02 %
3i Group PLC 2.21 %
Recruit Holdings Co Ltd. 2.19 %
MS&AD Insurance Group Holdings Inc. 2.18 %
Banco Santander, S.A. 2.08 %
InterContinental Hotels Group PLC 1.99 %
Adidas AG 1.82 %
Bayerische Motoren Werke AG 1.8 %
Fast Retailing Co Ltd. 1.8 %
More 1.8 %

Advisor

Documents

Prospectus

Annual Reports

Performance

YTD

3.1%

3 Year

-1.21%

5 Year

17.32%

Best

29.04%

2009

Worst

-46.07%

2008

Alpha

DOMAX S&P 500

Chart +